---
title: "10 Health Care Stocks Moving In Monday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289783700.md"
description: "In Monday's pre-market session, several healthcare stocks saw significant movement. Gelteq surged 50.5% to $1.49, while Quantum Cyber, Cypherpunk Technologies, and SS Innovations Intl also gained. Conversely, Elicio Therapeutics dropped 50.7% to $7.32. Other decliners included 20/20 Biolabs, Traws Pharma, Adicet Bio, Propanc Biopharma, and CollPlant Biotechnologies."
datetime: "2026-06-15T12:05:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289783700.md)
  - [en](https://longbridge.com/en/news/289783700.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289783700.md)
generator: "portal-rs"
---

# 10 Health Care Stocks Moving In Monday's Pre-Market Session

### Gainers

-   **Gelteq** (NASDAQ:GELS) shares moved upwards by 50.5% to $1.49 during Monday's pre-market session. The company's market cap stands at $10.6 million.
-   **Quantum Cyber** (NASDAQ:QUCY) shares moved upwards by 15.58% to $2.0. The market value of their outstanding shares is at $39.3 million.
-   **Cypherpunk Technologies** (NASDAQ:CYPH) stock moved upwards by 12.27% to $0.73. The market value of their outstanding shares is at $69.2 million.
-   **SS Innovations Intl** (NASDAQ:SSII) stock moved upwards by 11.01% to $3.73. The company's market cap stands at $672.4 million.

### Losers

-   **Elicio Therapeutics** (NASDAQ:ELTX) shares decreased by 50.7% to $7.32 during Monday's pre-market session. The company's market cap stands at $283.4 million.
-   **20/20 Biolabs** (NASDAQ:AIDX) shares fell 18.87% to $0.78. The market value of their outstanding shares is at $10.2 million.
-   **Traws Pharma** (NASDAQ:TRAW) shares fell 18.1% to $1.05. The market value of their outstanding shares is at $19.3 million.
-   **Adicet Bio** (NASDAQ:ACET) stock declined by 12.3% to $7.06. The market value of their outstanding shares is at $75.2 million.
-   **Propanc Biopharma** (NASDAQ:PPCB) shares decreased by 10.58% to $2.03. The market value of their outstanding shares is at $5.1 million.
-   **CollPlant Biotechnologies** (NASDAQ:CLGN) shares fell 8.73% to $0.31. The market value of their outstanding shares is at $4.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SSII.US](https://longbridge.com/en/quote/SSII.US.md)
- [ELTX.US](https://longbridge.com/en/quote/ELTX.US.md)
- [ACET.US](https://longbridge.com/en/quote/ACET.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [QUCY.US](https://longbridge.com/en/quote/QUCY.US.md)
- [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md)
- [AIDX.US](https://longbridge.com/en/quote/AIDX.US.md)
- [GELS.US](https://longbridge.com/en/quote/GELS.US.md)
- [TRAW.US](https://longbridge.com/en/quote/TRAW.US.md)
- [CYPH.US](https://longbridge.com/en/quote/CYPH.US.md)
- [MYNZ.US](https://longbridge.com/en/quote/MYNZ.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)

## Related News & Research

- [Propanc Biopharma plans first-in-human Phase 1b trial of PRP in up to 40 advanced solid tumor patients](https://longbridge.com/en/news/296229103.md)
- [TRAW: Net loss increased, cash is insufficient for 12 months, and Nasdaq delisting risk remains high](https://longbridge.com/en/news/295974913.md)
- [CollPlant Shareholders Approve All Proposals at August 18 Extraordinary Meeting](https://longbridge.com/en/news/296278507.md)
- [CollPlant Biotechnologies holds extraordinary shareholder meeting](https://longbridge.com/en/news/296270729.md)
- [Winklevoss-Backed Zcash faces Funding Crunch As $37.8M loss Puts Cancer Drug In The Spotlight](https://longbridge.com/en/news/295885103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**